OMC
50
-16
VRSK
68
-12
HRB
59
2
SNA
70
-5
CAT
59
-2
EW
32
3
IR
63
-3
AXP
67
-2
EMR
71
-3
TSN
50
-2
FE
44
5
HPE
44
-2
R
70
-3
SWKS
38
-2
SYY
49
9
ADM
28
3
TGNA
50
-6
DIS
85
3
AON
54
2
INTC
41
4
OMC
50
-16
VRSK
68
-12
HRB
59
2
SNA
70
-5
CAT
59
-2
EW
32
3
IR
63
-3
AXP
67
-2
EMR
71
-3
TSN
50
-2
FE
44
5
HPE
44
-2
R
70
-3
SWKS
38
-2
SYY
49
9
ADM
28
3
TGNA
50
-6
DIS
85
3
AON
54
2
INTC
41
4
Financhill
Back

RiverNorth Managed Duration Municipal Income Fund II Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
35

RMMZ
RiverNorth Managed Duration Municipal Income Fund II

Last Price:
15.74
Seasonality Move:
12.29%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
35
RiverNorth Managed Duration Municipal Income Fund II (RMMZ) is a Sell

Is RiverNorth Managed Duration Municipal Income Fund II a Buy, Sell or Hold?

  • The current RiverNorth Managed Duration Municipal Income Fund II [RMMZ] share price is $15.70. The Score for RMMZ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RMMZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RMMZ Stock Price Chart

What is RiverNorth Managed Duration Municipal Income Fund II's stock price today?

  • The RiverNorth Managed Duration Municipal Income Fund II share price today is $15.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMMZ is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RMMZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.17 Sell
Chaikin Money Flow: -37061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.76 - 16.28) Sell
Bollinger Bands (100): (15.87 - 16.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RMMZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.84 Sell
20-day SMA: 15.93 Sell
50-day SMA: 16.12 Sell
200-day SMA: 15.99 Sell
8-day EMA: 15.85 Sell
20-day EMA: 15.94 Sell
50-day EMA: 16.04 Sell
200-day EMA: 15.92 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

RiverNorth Managed Duration Municipal Income Fund II Earnings Growth & RMMZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

RiverNorth Managed Duration Municipal Income Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):